biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by rustycaton Dec 04, 2017 10:43am

141 Views

Post# 27084549

RE:RE:RE:Bioasis Implements Transition Plan for Board of Directors

Just a pretty complete wiping out of management, scientists and BOD. I heard from an attendee at the Calgary meeting that Dr. Day totally slagged management and spoke of his ability to right the ship with his experience and selection of top-tier biotechers. I believe he made mention to BTI's previous inability to bring home the bacon on deals that should have been made. Looks like it just wasn't posturing but a promise to bring BTI into the big leagues. Frankly, I'm all for it.

Bullboard Posts

Investing with insurance and protection